T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRED
1051
DELISTED
Fred's Inc
FRED
| $25.2M | 0.01% |
1,645,914
-5,100
| -0.3% | -$85.4K |
|
1052
Old Dominion Freight Line
ODFL
$44.1B
| $25M | 0.01% |
1,176,033
-189,501
| -14% | -$3.82M |
|
1053
TransDigm Group
TDG
$68.3B
| $24.9M | 0.01% |
148,854
+3,600
| +2% | +$649K |
|
1054
Gen Digital
GEN
$17.7B
| $24.8M | 0.01% |
1,083,838
+2,400
| +0.2% | +$51K |
|
1055
Transocean
RIG
$6.39B
| $24.8M | 0.01% |
550,349
+4,100
| +0.8% | +$174K |
|
|
UBA
1056
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $24.7M | 0.01% |
1,182,259
+263,809
| +29% | +$5.43M |
|
1057
Arcos Dorados Holdings
ARCO
$1.66B
| $24.6M | 0.01% |
2,261,418
-949,401
| -30% | -$8.95M |
|
1058
Dover
DOV
$28B
| $24.5M | 0.01% |
333,807
+4,333
| +1% | +$303K |
|
1059
Edwards Lifesciences
EW
$53.6B
| $24.4M | 0.01% |
1,702,950
-48,540
| -3% | -$658K |
|
1060
BorgWarner
BWA
$14B
| $24.3M | 0.01% |
423,751
+2,499
| +0.6% | +$138K |
|
1061
Matsons
MATX
$6.41B
| $24.1M | 0.01% |
899,151
+157,510
| +21% | +$3.84M |
|
1062
Copa Holdings
CPA
$6.14B
| $23.7M | 0.01% |
166,295
-39,130
| -19% | -$5.48M |
|
1063
Howard Hughes
HHH
$3.98B
| $23.6M | 0.01% |
156,747
-4,484
| -3% | -$625K |
|
1064
Oceaneering
OII
$5.08B
| $23.6M | 0.01% |
301,716
+10,403
| +4% | +$763K |
|
1065
MGIC Investment
MTG
$6.29B
| $23.5M | 0.01% |
2,542,440
+75,470
| +3% | +$655K |
|
|
DOOR
1066
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $23.4M | 0.01% |
415,525
+1,925
| +0.5% | +$105K |
|
1067
Saia
SAIA
$10.1B
| $23.3M | 0.01% |
+530,730
| New | +$22M |
|
1068
KLA
KLAC
$274B
| $23.3M | 0.01% |
3,205,050
+11,000
| +0.3% | +$73K |
|
1069
Maximus
MMS
$2.94B
| $23.2M | 0.01% |
540,300
+33,800
| +7% | +$1.45M |
|
1070
LivePerson
LPSN
$35.9M
| $23.2M | 0.01% |
152,533
-969
| -0.6% | -$145K |
|
1071
Pentair
PNR
$10.5B
| $23.2M | 0.01% |
478,648
+26,192
| +6% | +$1.33M |
|
1072
RE/MAX Holdings
RMAX
$263M
| $23.1M | 0.01% |
780,040
+29,545
| +4% | +$837K |
|
|
CALD
1073
DELISTED
Callidus Software, Inc.
CALD
| $23M | 0.01% |
1,928,170
+10,400
| +0.5% | +$111K |
|
|
BKYF
1074
DELISTED
BK KY FINL CORP
BKYF
| $23M | 0.01% |
660,670
+18,050
| +3% | +$630K |
|
1075
Robert Half
RHI
$4.25B
| $23M | 0.01% |
481,414
-280,070
| -37% | -$12.5M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.